These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8018929)
1. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Bordin JO; Bardossy L; Blajchman MA Blood; 1994 Jul; 84(1):344-8. PubMed ID: 8018929 [TBL] [Abstract][Full Text] [Related]
2. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion. Blajchman MA; Bardossy L; Carmen RA; Goldman M; Heddle NM; Singal DP Blood; 1992 Mar; 79(5):1371-5. PubMed ID: 1536960 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blajchman MA; Bardossy L; Carmen R; Sastry A; Singal DP Blood; 1993 Apr; 81(7):1880-2. PubMed ID: 8461473 [TBL] [Abstract][Full Text] [Related]
4. The tumor growth-promoting effect of allogeneic blood transfusions. Blajchman MA; Bordin JO Immunol Invest; 1995; 24(1-2):311-7. PubMed ID: 7713592 [TBL] [Abstract][Full Text] [Related]
5. Expression of Fas and Fas ligand on spleen T cells of experimental animals after unmodified or leukoreduced allogeneic blood transfusions. Hashimoto MN; Kimura EY; Yamamoto M; Bordin JO Transfusion; 2004 Feb; 44(2):158-63. PubMed ID: 14962305 [TBL] [Abstract][Full Text] [Related]
7. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820 [TBL] [Abstract][Full Text] [Related]
8. Introduction of universal prestorage leukodepletion of blood components, and outcomes in transfused cardiac surgery patients. McQuilten ZK; Andrianopoulos N; van de Watering L; Aubron C; Phillips L; Bellomo R; Pilcher D; Cameron P; Reid CM; Cole-Sinclair MF; Newcomb A; Smith J; McNeil JJ; Wood EM J Thorac Cardiovasc Surg; 2015 Jul; 150(1):216-22. PubMed ID: 25940409 [TBL] [Abstract][Full Text] [Related]
9. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Clark DA; Gorczynski RM; Blajchman MA Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594 [TBL] [Abstract][Full Text] [Related]
10. Influence of the timing of blood transfusion on experimental tumor growth. Francis DM; Clunie GJ J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239 [TBL] [Abstract][Full Text] [Related]
11. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma. Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101 [TBL] [Abstract][Full Text] [Related]
12. Poststorage leuko-depleted plasma inhibits T-cell proliferation and Th1 response in vitro: characterization of TGFbeta-1 as an important immunomodulatory component in stored blood. Hodge GL; Hodge SJ; Nairn J; Tippett E; Holmes M; Reynolds PN Transplantation; 2005 Jul; 80(1):95-101. PubMed ID: 16003239 [TBL] [Abstract][Full Text] [Related]
13. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness. Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Blajchman MA Vox Sang; 1998; 74 Suppl 2():315-9. PubMed ID: 9704462 [TBL] [Abstract][Full Text] [Related]
15. Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. Shirwadkar S; Blajchman MA; Frame B; Singal DP J Cancer Res Clin Oncol; 1992; 118(3):176-80. PubMed ID: 1548281 [TBL] [Abstract][Full Text] [Related]
16. Guideline development for prevention of transfusion-associated graft-versus-host disease: reduction of indications for irradiated blood components after prestorage leukodepletion of blood components. Wiersum-Osselton JC; Slomp J; Frederik Falkenburg JH; Geltink T; van Duijnhoven HLP; Netelenbos T; Schipperus MR Br J Haematol; 2021 Dec; 195(5):681-688. PubMed ID: 34490619 [TBL] [Abstract][Full Text] [Related]
18. Effect of blood transfusion on survival in a mouse bacterial peritonitis model. Goldman M; Frame B; Singal DP; Blajchman MA Transfusion; 1991 Oct; 31(8):710-2. PubMed ID: 1926314 [TBL] [Abstract][Full Text] [Related]
19. Effect of blood transfusion in an experimental sarcoma model. Lin HS; Samy RN; Lum J; Dorie MJ; Terris DJ Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):308-12. PubMed ID: 11886349 [TBL] [Abstract][Full Text] [Related]
20. The effect of blood transfusion on tumor growth in sarcoma-bearing rats. Newman E; Ho M; Heslin MJ; Chapman DS; Brennan MF Ann Surg Oncol; 1996 Jan; 3(1):74-9. PubMed ID: 8770306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]